Isolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743)

British Journal of Cancer

Volumn 82, Issue 10, 2000, Pages 1732-1739

  Erba, E ^a   Bergamaschi, D ^a   Bassano, L ^a   Ronzoni, S ^a   Di Liberti, G ^a   Muradore, I ^a   Vignati, S ^a   Faircloth, G ^b   Jimeno, J ^c   D'Incalci, M ^a  

^a Laboratory of Cancer Pharmacology   (Italy)

^b PharmaMar USA Inc   (United States)

^c PHARMAMAR S A   (Spain)

Author keywords

Drug resistance; Ecteinascidin 743; Natural compound; P gp expression

Indexed keywords

ANTINEOPLASTIC ALKALOID; CYCLOSPORIN DERIVATIVE; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; MESSENGER RNA; OXALIPLATIN; TRABECTEDIN;

ARTICLE; CANCER CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; CROSS RESISTANCE; CULTURE MEDIUM; DRUG ACTIVITY; DRUG TRANSPORT; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; DIOXOLES; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENES, MDR; HUMANS; ISOQUINOLINES; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; TETRAHYDROISOQUINOLINES; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0034099849     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bénard J, Da Silva J, De Blois M, Boyer P, Duvillard P, Chiric E and Riou G (1985) Characterization of human ovarian adenocarcinoma line, IGROV 1, in tissue culture and in nude mice. Cancer Res 45: 4970-4979
2. Binaschi M, Supino R, Gambetta RA, Giaccone G, Prosperi E, Capranico G and Zunino F (1995) MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistance. Int J Cancer 62: 84-89
3. Boesch D, Muller K, Pourtier-Manzanedo A and Loor F (1991) Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a non-immunosuppressive cyclosporin derivative. Exp Cell Res 196: 26-32
4. Bonfanti M, La Valle E, Fernandez Sousa Faro J-M, Faircloth G, Caretti G, Mantovani R and D'Incalci M (1999) Effect of ecteinascidin-743 (ET-743) on the interaction between DNA bindings proteins and DNA. Anti-cancer Drug Des 14: 179-186
5. Broggini M, Grandi M, Ubezio P, Geroni C, Giuliani FC and D'Incalci M (1988) Intracellular doxorubicin concentrations and drug induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline. Biochem Pharmacol 37: 4423-4431
6. Cvitkovic E, Riofrio M, Goldwasser F, Delaloge S, Taamma A, Bijnen J, Jimeno JM, Mekranter B, Guzman C, Brain E and Misset JL (1999) Final results of phase 1 study of ecteinascidin-743 (ET-743) 24 hour (h) continuous infusion (CI) in advanced solid tumors (AST) patients (pts). Proc ASCO 18: 180a
7. Erba E, Balconi G, Faretta M, Bergamaschi D, Guidi G, Jimeno J, Faircloth and D'Incalci M (1996) Cell cycle phases perturbations induced by new natural marine compounds. Ann Oncol 7: 82
8. Ferrero M, Spyratos F, Le Doussal V, Desplaces A and Rouesse J (1990) Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors. Cytometry 11: 716-724
9. Ghielmini M, Colli E, Erba E, Bergamaschi D, Pampallona S, Jimeno J, Faircloth G and Sessa C (1998) In vitro schedule-dependency of myelotoxicity and cytotoxicity of Ecteinascidin 743 (ET-743). Ann Oncol 9: 989-993
10. Guan Y, Sakai R, Rinehart KL and Wang AHJ (1993) Molecular and crystal structures of ecteinascidins: Potent antitumor compounds from the Caribbean tunicate Ecteinascidia turbinata. J Biomol Struct Dyn 10: 793-818
11. Jimeno JM, Faircloth G, Cameron L, Meely K, Vega E, Gomez A, FernandezSousa-Faro JM and Rinehart K (1996) Progress in the acquisition of new marine-derived anticancer compounds: Development of ecteinascidin-743 (ET-743). Drugs Fut 21: 1155-1165
12. Jin S, Lin Y, Magro PG and Scotto KW (1999) Repression of MDR1 gene transcription by ecteinascidin 743. Proc Am Ass Cancer Res 40: 314
13. Krishan A, Sauerteig A, Andritsch I and Wellham L (1997) Flow cytometric analysis of the multiple drug resistance phenotype. Leukemia 11: 1138-1146
14. Limonta M, Ubezio P, Catapano CV, Conter V, Costato C, Specchia G, Liso V, Barbui T, Giudici G and D'Incalci M (1991) Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patients. Leukemia Res 15: 19-24
15. Moore H, BM, Seaman FC and Hurley LH (1997) NMR-based model of an ecteinascidin 743-DNA adduct. J Am Chem Soc 119: 5475-5476
16. Pommier Y, Kohlhagen G, Bailly C, Waring M, Mazumder A and Kohn KW (1996) DNA sequence-and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata. Biochemistry 35: 13303-13309
17. Rayan DP, Supko JG, Eder JP, Lu H, Chabner B, Roper K, Baccala P, Bonefant J, Faircloth G, Guzman C, Jimeno J and Clark JW (1999) A phase 1 and pharmacokinetic trial of ecteinacidin-743 (ET-743) administered as a 72 hour continuous infusion. Proc ASCO 18: 188a
18. Rinehart KL, Holt TG, Fregeau NL, Stroh JG, Keifer PA, Li LH and Martin DG (1990) Ecteinascidins 729, 743, 745, 759A, 759B, and 770: Potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. J Org Chem 55: 4512-4515
19. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
20. Valoti G, Nicoletti MI, Pellegrino A, Jimeno J, Hendriks H, D'Incalci M, Faircloth G and Giavazzi R (1998) Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts. Clin Cancer Res 4: 1977-1983
21. Zewail-Foote M and Hurley LH (1999) Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove. J Med Chem 42: 2493-2497